Novo Nordisk shares drop nearly 5% on disappointing obesity pill data
By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -Novo Nordisk’s shares fell nearly 5% on Friday after results from a…
September 20, 2024
US FDA approves Zevra’s treatment for rare genetic disease
(Reuters) -The U.S. Food and Drug Administration has approved Zevra Therapeutics’ drug for a rare and fatal genetic disorder, making…
Nike veteran Hill to replace Donahoe as CEO; shares jump
By Juveria Tabassum, Nicholas P. Brown (Reuters) -Nike said on Thursday that former senior executive Elliott Hill will rejoin the…
Fed’s relaxed bank-capital plan faces FDIC pushback, Bloomberg News reports
(Reuters) – The U.S. Federal Reserve’s watered-down version of a landmark bank capital proposal is facing resistance from the Federal…